Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device/drug catastrophic liability insurance risk pool offered by Capital Risk Strategies.

This article was originally published in The Gray Sheet

Executive Summary

PRODUCT LIABILITY CATASTROPHIC CLAIM INSURANCE RISK POOL OF $4 BIL. is being offered by Capital Risk Strategies of New York City to the medical device and pharmaceutical industries as an addition to self-insuring. The idea behind the finite risk insurance is shared limits for product liability suits with long-term coverage of 10 years. Capital Risk is providing $1.6 bil. through the sale of future premium receivables as a structured finance vehicle in the capital markets. The remainder of the funding is being provided by reinsurers.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005427

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel